among those that potentiate OS are carbohydrate metabolism dysregulation leading to advanced glycation end products, lipid profile abnormalities resulting in plasma lipid oxidation, immune system activation triggering proinflammatory cytokine release, renal hypoxia, and the adverse effects of steroid or immunosuppressant therapy
Semaglutide, marketed as Wegovy for weight management, has gained particular attention for its efficacy in clinical trials
Metformin is another popular and effective option, and according to the American Diabetes Association, DPP-4 inhibitors, SGLT2 inhibitors, sulfonylureas, and thiazolidinediones are other viable alternatives
In addition, there are client assistance programs and manufacturer discounts to help you access Semaglutide GLP-1 treatment at a more affordable cost